Understanding how bacterial channels respond to mechanical forces
Elucidating the gating mechanisms of bacterial mechanosensitive channels
This study is looking at how tiny channels in bacteria respond to pressure, which helps them survive, and by understanding how these channels work, researchers hope to find new ways to create antibiotics that specifically target bacteria without affecting humans.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rockefeller University NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10986103 on NIH RePORTER |
What this research studies
This research investigates how mechanosensitive channels in bacteria open in response to mechanical forces, which is crucial for their survival. By studying these channels, researchers aim to uncover the mechanisms that control their opening and closing, which could lead to new antibiotic treatments. The approach involves advanced techniques like cryo-electron microscopy to visualize the channels in different states. This research is particularly significant because these channels are not present in humans, making them unique targets for drug development.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research would be individuals with bacterial infections that are resistant to current antibiotic treatments.
Not a fit: Patients with viral infections or non-bacterial conditions are unlikely to benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of novel antibiotics that specifically target bacterial mechanosensitive channels.
How similar studies have performed: Other research has shown promise in targeting bacterial channels for antibiotic development, indicating that this approach has potential for success.
Where this research is happening
New York, United States
- Rockefeller University — New York, United States (Active)
Researchers
- Principal investigator: Walz, Thomas — Rockefeller University
- Study coordinator: Walz, Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.